Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | PPARG | P37231 | 9/20 | 0.47 |
| ▸ | PPARA | Q07869 | 3/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | FBP1 | P09467 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | EP300 | Q09472 | 1/20 | 0.40 |
| ▸ | FABP3 | P05413 | 3/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1566733 | 1.00 | FAAH (0.50) | FAAHPPARGPPARATRPA1FBP1 | |
| SCHEMBL23941092 | 0.81 | CYP1A2 (0.51) | FAAHCYP1A2CYP2C19ALDH1A1LMNA | |
| SCHEMBL6369893 | 0.78 | PPARG (0.58) | FAAHPPARGPPARATRPA1FBP1 | |
| SCHEMBL21925331 | 0.78 | PPARG (0.58) | FAAHPPARGPPARATRPA1FBP1 | |
| SCHEMBL21925330 | 0.78 | PPARG (0.58) | FAAHPPARGPPARATRPA1FBP1 | |
| SCHEMBL6369891 | 0.78 | PPARG (0.58) | FAAHPPARGPPARATRPA1FBP1 | |
| SCHEMBL16110273 | 0.77 | CYP1A2 (0.52) | FAAHCYP1A2CYP2C19ALDH1A1LMNA | |
| SCHEMBL17674143 | 0.77 | CYP1A2 (0.54) | FAAHCYP1A2CYP2C19ALDH1A1LMNA | |
| SCHEMBL17674145 | 0.77 | CYP1A2 (0.54) | FAAHCYP1A2CYP2C19ALDH1A1LMNA | |
| SCHEMBL14706091 | 0.77 | CYP1A2 (0.54) | FAAHCYP1A2CYP2C19ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9012038-B2 | Phosphorescent metal complex compound, method for the preparation thereof and radiating component | OSRAM GMBH (DE) | 2015-04-21 | — | — | US | disclosed |
| EP-2307430-B1 | PHOSPHORESCENT METAL COMPLEX COMPOUND, METHOD FOR THE PREPARATION THEREOF AND RADIATING COMPONENT | OSRAM GMBH (DE) | 2014-08-27 | — | — | EP | disclosed |
| US-20110187265-A1 | PHOSPHORESCENT METAL COMPLEX COMPOUND, METHOD FOR THE PREPARATION THEREOF AND RADIATING COMPONENT | OSRAM OLED GMBH (DE) | 2011-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110187265-A1 | PHOSPHORESCENT METAL COMPLEX COMPOUND, METHOD FOR THE PREPARATION THEREOF AND RADIATING COMPONENT | OSTC, ORC3, OSBP | FAAH 4878/4885PPARG 1911/4885PPARA 1528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.